Gene Symbol | Gene ID | Gene Info |
---|---|---|
Klf12
|
ENSMUSG00000072294.4 | Kruppel-like factor 12 |
Klf14
|
ENSMUSG00000073209.3 | Kruppel-like factor 14 |
Sp4
|
ENSMUSG00000025323.9 | trans-acting transcription factor 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr14_100133351_100133538 | Klf12 | 16320 | 0.241805 | 0.94 | 5.8e-03 | Click! |
chr14_100263160_100263351 | Klf12 | 21229 | 0.166767 | 0.88 | 2.1e-02 | Click! |
chr14_100134930_100135207 | Klf12 | 14696 | 0.244765 | 0.80 | 5.4e-02 | Click! |
chr14_100264527_100264923 | Klf12 | 19759 | 0.170133 | 0.77 | 7.6e-02 | Click! |
chr14_100134133_100134314 | Klf12 | 15541 | 0.243235 | 0.71 | 1.1e-01 | Click! |
chr12_118298820_118298984 | Sp4 | 2466 | 0.380631 | 0.80 | 5.9e-02 | Click! |
chr12_118367177_118367388 | Sp4 | 65842 | 0.124674 | 0.76 | 8.1e-02 | Click! |
chr12_118359209_118359360 | Sp4 | 57844 | 0.142848 | -0.73 | 9.8e-02 | Click! |
chr12_118290855_118291147 | Sp4 | 10367 | 0.256483 | -0.71 | 1.2e-01 | Click! |
chr12_118299403_118299566 | Sp4 | 1884 | 0.444763 | -0.70 | 1.2e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_48984872_48985421 | 5.71 |
Usp28 |
ubiquitin specific peptidase 28 |
229 |
0.92 |
chr5_140389137_140389453 | 5.19 |
Snx8 |
sorting nexin 8 |
33 |
0.97 |
chr7_29211431_29211967 | 5.17 |
Catsperg1 |
cation channel sperm associated auxiliary subunit gamma 1 |
204 |
0.86 |
chr10_81106442_81106775 | 5.15 |
Map2k2 |
mitogen-activated protein kinase kinase 2 |
263 |
0.76 |
chr4_133220772_133220938 | 4.43 |
Cd164l2 |
CD164 sialomucin-like 2 |
45 |
0.96 |
chr19_61226929_61227456 | 4.05 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
44 |
0.96 |
chr11_75173089_75173918 | 3.95 |
Mir212 |
microRNA 212 |
115 |
0.56 |
chr11_53430880_53431283 | 3.79 |
Gdf9 |
growth differentiation factor 9 |
58 |
0.73 |
chr18_80200615_80200779 | 3.65 |
Rbfa |
ribosome binding factor A |
39 |
0.94 |
chr17_32492701_32492868 | 3.25 |
Cyp4f39 |
cytochrome P450, family 4, subfamily f, polypeptide 39 |
626 |
0.63 |
chr5_99252774_99253080 | 3.24 |
Rasgef1b |
RasGEF domain family, member 1B |
0 |
0.98 |
chr18_46597468_46597778 | 3.18 |
Eif1a |
eukaryotic translation initiation factor 1A |
78 |
0.5 |
chr10_80329677_80330103 | 3.14 |
Reep6 |
receptor accessory protein 6 |
63 |
0.81 |
chr15_97908200_97908485 | 3.07 |
Vdr |
vitamin D (1,25-dihydroxyvitamin D3) receptor |
32 |
0.98 |
chr11_100493828_100493979 | 2.96 |
Acly |
ATP citrate lyase |
296 |
0.81 |
chr15_73512350_73512586 | 2.95 |
Dennd3 |
DENN/MADD domain containing 3 |
92 |
0.97 |
chr10_81600790_81601143 | 2.81 |
Tle6 |
transducin-like enhancer of split 6 |
66 |
0.93 |
chr2_156008335_156008486 | 2.79 |
Ergic3 |
ERGIC and golgi 3 |
187 |
0.72 |
chr10_80577672_80578424 | 2.79 |
Klf16 |
Kruppel-like factor 16 |
727 |
0.41 |
chr10_81378463_81379124 | 2.77 |
Fzr1 |
fizzy and cell division cycle 20 related 1 |
277 |
0.71 |
chr7_44553292_44553632 | 2.76 |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
224 |
0.8 |
chr10_80343063_80343448 | 2.73 |
Adamtsl5 |
ADAMTS-like 5 |
1983 |
0.12 |
chr18_5819758_5819934 | 2.69 |
Zeb1 |
zinc finger E-box binding homeobox 1 |
88765 |
0.08 |
chr8_11921702_11921858 | 2.64 |
Gm45680 |
predicted gene 45680 |
26517 |
0.14 |
chr8_122324060_122324293 | 2.59 |
Zfpm1 |
zinc finger protein, multitype 1 |
9522 |
0.13 |
chr2_33370578_33371002 | 2.54 |
Ralgps1 |
Ral GEF with PH domain and SH3 binding motif 1 |
639 |
0.68 |
chr8_120518855_120519006 | 2.52 |
Gm26971 |
predicted gene, 26971 |
1685 |
0.26 |
chr15_84680863_84681030 | 2.48 |
Prr5 |
proline rich 5 (renal) |
56 |
0.98 |
chr15_25622272_25622843 | 2.38 |
Myo10 |
myosin X |
8 |
0.98 |
chr17_6317311_6317624 | 2.37 |
Dynlt1a |
dynein light chain Tctex-type 1A |
33 |
0.96 |
chr5_125525361_125525537 | 2.37 |
Tmem132b |
transmembrane protein 132B |
6325 |
0.17 |
chrY_90740044_90740606 | 2.36 |
Mid1-ps1 |
midline 1, pseudogene 1 |
12732 |
0.18 |
chr7_4470400_4470562 | 2.32 |
Gm15494 |
predicted gene 15494 |
768 |
0.4 |
chr7_128238185_128238560 | 2.30 |
9130023H24Rik |
RIKEN cDNA 9130023H24 gene |
341 |
0.67 |
chr4_83623239_83623558 | 2.23 |
Gm27046 |
predicted gene, 27046 |
26095 |
0.17 |
chr5_142938438_142938600 | 2.22 |
Fscn1 |
fascin actin-bundling protein 1 |
21824 |
0.13 |
chr15_82987815_82987989 | 2.20 |
Tcf20 |
transcription factor 20 |
30 |
0.53 |
chr15_7132721_7132879 | 2.20 |
Lifr |
LIF receptor alpha |
3228 |
0.35 |
chr7_19404092_19404290 | 2.14 |
Klc3 |
kinesin light chain 3 |
87 |
0.85 |
chr4_47352960_47353255 | 2.11 |
Tgfbr1 |
transforming growth factor, beta receptor I |
115 |
0.97 |
chr7_19749535_19749718 | 2.10 |
Nectin2 |
nectin cell adhesion molecule 2 |
53 |
0.93 |
chr14_65343757_65343932 | 2.07 |
Zfp395 |
zinc finger protein 395 |
14545 |
0.15 |
chr5_129941480_129942081 | 2.05 |
Vkorc1l1 |
vitamin K epoxide reductase complex, subunit 1-like 1 |
190 |
0.89 |
chr1_21079133_21079530 | 2.05 |
Tram2 |
translocating chain-associating membrane protein 2 |
102 |
0.92 |
chr8_125569857_125570144 | 2.04 |
Sipa1l2 |
signal-induced proliferation-associated 1 like 2 |
192 |
0.96 |
chr3_89149981_89150132 | 2.03 |
Hcn3 |
hyperpolarization-activated, cyclic nucleotide-gated K+ 3 |
1158 |
0.23 |
chr4_141060479_141060918 | 2.00 |
Crocc |
ciliary rootlet coiled-coil, rootletin |
148 |
0.92 |
chr8_70905885_70906054 | 2.00 |
Map1s |
microtubule-associated protein 1S |
13 |
0.94 |
chr7_7298323_7298607 | 1.98 |
Clcn4 |
chloride channel, voltage-sensitive 4 |
281 |
0.58 |
chr10_70599314_70599473 | 1.96 |
Phyhipl |
phytanoyl-CoA hydroxylase interacting protein-like |
102 |
0.98 |
chr10_77902990_77903176 | 1.96 |
Lrrc3 |
leucine rich repeat containing 3 |
547 |
0.54 |
chr11_61684235_61684526 | 1.95 |
Fam83g |
family with sequence similarity 83, member G |
39 |
0.97 |
chr11_69948204_69948362 | 1.95 |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
95 |
0.89 |
chr3_145924039_145924997 | 1.93 |
Bcl10 |
B cell leukemia/lymphoma 10 |
161 |
0.95 |
chr2_156196483_156196801 | 1.92 |
Phf20 |
PHD finger protein 20 |
0 |
0.97 |
chr2_36091235_36091637 | 1.90 |
Lhx6 |
LIM homeobox protein 6 |
2837 |
0.18 |
chr17_6430021_6430185 | 1.83 |
Dynlt1b |
dynein light chain Tctex-type 1B |
9 |
0.97 |
chr9_20990940_20991108 | 1.77 |
Mrpl4 |
mitochondrial ribosomal protein L4 |
11714 |
0.07 |
chr9_121241919_121242070 | 1.76 |
Gm17157 |
predicted gene 17157 |
5323 |
0.18 |
chr13_107371972_107372123 | 1.73 |
Gm2736 |
predicted gene 2736 |
23843 |
0.19 |
chr16_18036509_18036685 | 1.73 |
Gm49580 |
predicted gene, 49580 |
7918 |
0.13 |
chr10_81167707_81168009 | 1.73 |
Pias4 |
protein inhibitor of activated STAT 4 |
65 |
0.92 |
chr2_140394932_140395719 | 1.71 |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
16 |
0.98 |
chr9_86571752_86572027 | 1.71 |
Pgm3 |
phosphoglucomutase 3 |
47 |
0.56 |
chr2_134544863_134545049 | 1.71 |
Hao1 |
hydroxyacid oxidase 1, liver |
9351 |
0.3 |
chr2_155386048_155386359 | 1.71 |
Trp53inp2 |
transformation related protein 53 inducible nuclear protein 2 |
4001 |
0.16 |
chr3_96102273_96102454 | 1.71 |
Otud7b |
OTU domain containing 7B |
2164 |
0.17 |
chr8_81014869_81015237 | 1.70 |
Gm9725 |
predicted gene 9725 |
90 |
0.55 |
chr1_40790630_40790792 | 1.69 |
Mfsd9 |
major facilitator superfamily domain containing 9 |
24 |
0.97 |
chr10_58322882_58323675 | 1.68 |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
188 |
0.94 |
chr2_30286279_30286440 | 1.67 |
Dolk |
dolichol kinase |
25 |
0.5 |
chr4_107923552_107923707 | 1.66 |
Cpt2 |
carnitine palmitoyltransferase 2 |
19 |
0.97 |
chr12_111150300_111150468 | 1.66 |
Traf3 |
TNF receptor-associated factor 3 |
15986 |
0.15 |
chr13_55513380_55513744 | 1.65 |
Pdlim7 |
PDZ and LIM domain 7 |
114 |
0.91 |
chr3_116662611_116662785 | 1.61 |
Mfsd14a |
major facilitator superfamily domain containing 14A |
21 |
0.93 |
chr19_46328692_46329074 | 1.58 |
Fbxl15 |
F-box and leucine-rich repeat protein 15 |
696 |
0.41 |
chr7_122021126_122021430 | 1.57 |
Gga2 |
golgi associated, gamma adaptin ear containing, ARF binding protein 2 |
56 |
0.96 |
chr7_29212161_29212479 | 1.56 |
Catsperg1 |
cation channel sperm associated auxiliary subunit gamma 1 |
825 |
0.39 |
chr14_120830490_120830770 | 1.56 |
Gm9391 |
predicted gene 9391 |
3472 |
0.2 |
chr5_65431249_65431409 | 1.54 |
Gm43289 |
predicted gene 43289 |
251 |
0.83 |
chr7_45510337_45510716 | 1.54 |
Nucb1 |
nucleobindin 1 |
120 |
0.87 |
chr13_56522143_56522555 | 1.53 |
Fbxl21 |
F-box and leucine-rich repeat protein 21 |
123 |
0.96 |
chr8_122046811_122046964 | 1.52 |
Banp |
BTG3 associated nuclear protein |
46040 |
0.11 |
chr11_116624217_116624394 | 1.51 |
Rhbdf2 |
rhomboid 5 homolog 2 |
58 |
0.95 |
chr15_75886878_75887040 | 1.50 |
Mroh6 |
maestro heat-like repeat family member 6 |
1811 |
0.16 |
chr1_130715772_130716198 | 1.50 |
Pfkfb2 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
171 |
0.49 |
chr4_107253452_107253814 | 1.50 |
Hspb11 |
heat shock protein family B (small), member 11 |
40 |
0.56 |
chr19_36409278_36409914 | 1.49 |
Pcgf5 |
polycomb group ring finger 5 |
152 |
0.94 |
chr12_64918124_64918389 | 1.47 |
Gm527 |
predicted gene 527 |
287 |
0.89 |
chr8_123126291_123126452 | 1.47 |
Cpne7 |
copine VII |
146 |
0.89 |
chr9_55283614_55283814 | 1.47 |
Nrg4 |
neuregulin 4 |
89 |
0.97 |
chr4_129500365_129501120 | 1.45 |
Gm12979 |
predicted gene 12979 |
9004 |
0.08 |
chr1_69108507_69108672 | 1.44 |
Erbb4 |
erb-b2 receptor tyrosine kinase 4 |
530 |
0.75 |
chr6_37870282_37871066 | 1.44 |
Trim24 |
tripartite motif-containing 24 |
137 |
0.96 |
chr7_118995192_118995343 | 1.44 |
Gprc5b |
G protein-coupled receptor, family C, group 5, member B |
56 |
0.98 |
chr8_84872118_84872282 | 1.44 |
Syce2 |
synaptonemal complex central element protein 2 |
7 |
0.93 |
chr9_114731036_114731195 | 1.43 |
Cmtm6 |
CKLF-like MARVEL transmembrane domain containing 6 |
1 |
0.97 |
chr14_50924662_50925001 | 1.41 |
Osgep |
O-sialoglycoprotein endopeptidase |
1 |
0.62 |
chr9_49365685_49366095 | 1.41 |
Drd2 |
dopamine receptor D2 |
25263 |
0.2 |
chr6_90989097_90989257 | 1.38 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
492 |
0.81 |
chr3_30855609_30856108 | 1.38 |
Gpr160 |
G protein-coupled receptor 160 |
92 |
0.96 |
chr6_48086500_48086790 | 1.38 |
Zfp746 |
zinc finger protein 746 |
52 |
0.97 |
chr15_85735264_85735747 | 1.37 |
Ppara |
peroxisome proliferator activated receptor alpha |
59 |
0.97 |
chr1_66816824_66817235 | 1.36 |
Kansl1l |
KAT8 regulatory NSL complex subunit 1-like |
517 |
0.58 |
chr8_80739304_80739737 | 1.36 |
Smarca5 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 |
23 |
0.98 |
chr11_78246150_78246317 | 1.36 |
Supt6 |
SPT6, histone chaperone and transcription elongation factor |
246 |
0.65 |
chr12_81043680_81043838 | 1.34 |
Smoc1 |
SPARC related modular calcium binding 1 |
16931 |
0.19 |
chr7_18893627_18893802 | 1.34 |
Ccdc61 |
coiled-coil domain containing 61 |
245 |
0.86 |
chr6_70790951_70791123 | 1.31 |
Rpia |
ribose 5-phosphate isomerase A |
966 |
0.51 |
chr18_23803826_23803999 | 1.30 |
Mapre2 |
microtubule-associated protein, RP/EB family, member 2 |
72 |
0.97 |
chr5_107359463_107359814 | 1.30 |
Brdt |
bromodomain, testis-specific |
199 |
0.91 |
chr2_163750130_163750300 | 1.29 |
Ada |
adenosine deaminase |
24 |
0.98 |
chr16_90810428_90810591 | 1.29 |
Urb1 |
URB1 ribosome biogenesis 1 homolog (S. cerevisiae) |
96 |
0.96 |
chr2_24935268_24935432 | 1.29 |
Arrdc1 |
arrestin domain containing 1 |
98 |
0.91 |
chr4_120731050_120731227 | 1.27 |
Kcnq4 |
potassium voltage-gated channel, subfamily Q, member 4 |
16110 |
0.12 |
chr17_46383354_46383711 | 1.26 |
Zfp318 |
zinc finger protein 318 |
199 |
0.91 |
chr2_3713275_3713436 | 1.26 |
Fam107b |
family with sequence similarity 107, member B |
103 |
0.96 |
chr4_133887759_133887933 | 1.25 |
Rps6ka1 |
ribosomal protein S6 kinase polypeptide 1 |
49 |
0.96 |
chr9_44087034_44087185 | 1.25 |
Usp2 |
ubiquitin specific peptidase 2 |
81 |
0.91 |
chr6_52012561_52012870 | 1.25 |
Gm44077 |
predicted gene, 44077 |
114 |
0.57 |
chr4_142015030_142015185 | 1.24 |
Fhad1 |
forkhead-associated (FHA) phosphopeptide binding domain 1 |
25 |
0.96 |
chr17_35186094_35186252 | 1.24 |
Lst1 |
leukocyte specific transcript 1 |
2266 |
0.07 |
chr19_24039597_24039753 | 1.23 |
Fam189a2 |
family with sequence similarity 189, member A2 |
8656 |
0.18 |
chr4_140906204_140906355 | 1.22 |
Padi2 |
peptidyl arginine deiminase, type II |
65 |
0.96 |
chr4_137931021_137931190 | 1.22 |
Ece1 |
endothelin converting enzyme 1 |
17423 |
0.2 |
chr2_26445181_26445721 | 1.22 |
Sec16a |
SEC16 homolog A, endoplasmic reticulum export factor |
235 |
0.47 |
chr5_120503570_120503729 | 1.22 |
Plbd2 |
phospholipase B domain containing 2 |
24 |
0.96 |
chr7_35802959_35803128 | 1.21 |
Zfp507 |
zinc finger protein 507 |
40 |
0.88 |
chr4_43978549_43978700 | 1.20 |
Ccin |
calicin |
4859 |
0.15 |
chr11_95232020_95232325 | 1.20 |
Gm11515 |
predicted gene 11515 |
6540 |
0.15 |
chr4_143192114_143192277 | 1.19 |
Prdm2 |
PR domain containing 2, with ZNF domain |
2540 |
0.21 |
chr8_70158443_70158608 | 1.19 |
Mef2b |
myocyte enhancer factor 2B |
5744 |
0.09 |
chr11_76399155_76399316 | 1.18 |
Nxn |
nucleoredoxin |
95 |
0.97 |
chr17_34024149_34024494 | 1.18 |
Ring1 |
ring finger protein 1 |
331 |
0.42 |
chr4_48124787_48124966 | 1.18 |
Stx17 |
syntaxin 17 |
39 |
0.98 |
chr9_110985950_110986443 | 1.17 |
1700061E17Rik |
RIKEN cDNA 1700061E17 gene |
5 |
0.94 |
chr17_27908810_27909383 | 1.17 |
Taf11 |
TATA-box binding protein associated factor 11 |
43 |
0.7 |
chr11_78194878_78195242 | 1.17 |
Proca1 |
protein interacting with cyclin A1 |
314 |
0.7 |
chr4_32950872_32951028 | 1.15 |
Ankrd6 |
ankyrin repeat domain 6 |
109 |
0.96 |
chr16_56551155_56551324 | 1.14 |
Abi3bp |
ABI gene family, member 3 (NESH) binding protein |
73339 |
0.11 |
chr18_80046692_80046991 | 1.14 |
Pard6g |
par-6 family cell polarity regulator gamma |
49 |
0.94 |
chr5_130096864_130097028 | 1.14 |
Tpst1 |
protein-tyrosine sulfotransferase 1 |
3357 |
0.17 |
chr9_108263755_108264120 | 1.14 |
Dag1 |
dystroglycan 1 |
19 |
0.95 |
chr12_112628974_112629144 | 1.14 |
Adssl1 |
adenylosuccinate synthetase like 1 |
8966 |
0.11 |
chr4_136021746_136021908 | 1.13 |
Eloa |
elongin A |
64 |
0.94 |
chr7_28597835_28598003 | 1.13 |
Pak4 |
p21 (RAC1) activated kinase 4 |
167 |
0.56 |
chr4_19700601_19700753 | 1.12 |
Wwp1 |
WW domain containing E3 ubiquitin protein ligase 1 |
8316 |
0.22 |
chr3_102734781_102734932 | 1.12 |
Tspan2 |
tetraspanin 2 |
101 |
0.87 |
chr6_29216297_29216477 | 1.12 |
Impdh1 |
inosine monophosphate dehydrogenase 1 |
23 |
0.97 |
chr17_83350686_83350964 | 1.12 |
Eml4 |
echinoderm microtubule associated protein like 4 |
106 |
0.98 |
chr2_13573500_13574024 | 1.11 |
Vim |
vimentin |
165 |
0.96 |
chr14_67072405_67072747 | 1.11 |
Ppp2r2a |
protein phosphatase 2, regulatory subunit B, alpha |
132 |
0.95 |
chr7_45800554_45800731 | 1.10 |
Cyth2 |
cytohesin 2 |
10246 |
0.07 |
chr19_28834565_28834716 | 1.10 |
Slc1a1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
409 |
0.82 |
chr1_155417404_155417567 | 1.10 |
Xpr1 |
xenotropic and polytropic retrovirus receptor 1 |
70 |
0.98 |
chr10_17948008_17948419 | 1.09 |
Heca |
hdc homolog, cell cycle regulator |
146 |
0.97 |
chr6_30896643_30896992 | 1.09 |
Copg2 |
coatomer protein complex, subunit gamma 2 |
23 |
0.55 |
chr16_55815516_55815696 | 1.09 |
Nfkbiz |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, zeta |
2909 |
0.25 |
chr4_134879692_134879843 | 1.09 |
Rhd |
Rh blood group, D antigen |
43 |
0.97 |
chr11_76446356_76446516 | 1.09 |
Abr |
active BCR-related gene |
9216 |
0.19 |
chr2_31453653_31453813 | 1.08 |
Hmcn2 |
hemicentin 2 |
975 |
0.57 |
chr17_23592667_23592836 | 1.08 |
Zfp13 |
zinc finger protein 13 |
6519 |
0.08 |
chr8_110618464_110618624 | 1.08 |
Vac14 |
Vac14 homolog (S. cerevisiae) |
41 |
0.98 |
chr16_90197395_90197783 | 1.08 |
Gm49704 |
predicted gene, 49704 |
559 |
0.72 |
chr10_117063716_117063975 | 1.08 |
Cct2 |
chaperonin containing Tcp1, subunit 2 (beta) |
31 |
0.97 |
chr18_80083127_80083293 | 1.08 |
Gm50195 |
predicted gene, 50195 |
3596 |
0.12 |
chr3_37419572_37419987 | 1.08 |
Spata5 |
spermatogenesis associated 5 |
117 |
0.59 |
chr16_93832786_93832958 | 1.08 |
Gm30881 |
predicted gene, 30881 |
147 |
0.85 |
chr9_99140239_99140424 | 1.08 |
Pik3cb |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
244 |
0.92 |
chr7_31053117_31053317 | 1.08 |
Fxyd1 |
FXYD domain-containing ion transport regulator 1 |
95 |
0.91 |
chr15_37007251_37007773 | 1.07 |
Gm26766 |
predicted gene, 26766 |
11 |
0.6 |
chr2_166786756_166786921 | 1.07 |
Trp53rkb |
transformation related protein 53 regulating kinase B |
5693 |
0.18 |
chr11_33931902_33932233 | 1.07 |
Kcnmb1 |
potassium large conductance calcium-activated channel, subfamily M, beta member 1 |
30946 |
0.19 |
chr11_62879314_62879482 | 1.07 |
Tvp23b |
trans-golgi network vesicle protein 23B |
57 |
0.96 |
chr11_23124778_23124929 | 1.07 |
1700061J23Rik |
RIKEN cDNA 1700061J23 gene |
27287 |
0.14 |
chr4_109202197_109202369 | 1.07 |
Osbpl9 |
oxysterol binding protein-like 9 |
11 |
0.98 |
chr10_4334368_4334532 | 1.07 |
Akap12 |
A kinase (PRKA) anchor protein (gravin) 12 |
95 |
0.97 |
chr5_33629553_33629907 | 1.06 |
Fam53a |
family with sequence similarity 53, member A |
95 |
0.63 |
chr4_45018519_45018677 | 1.06 |
Polr1e |
polymerase (RNA) I polypeptide E |
15 |
0.96 |
chr4_119733602_119733765 | 1.06 |
Hivep3 |
human immunodeficiency virus type I enhancer binding protein 3 |
101 |
0.97 |
chr2_25395744_25395917 | 1.06 |
Entpd2 |
ectonucleoside triphosphate diphosphohydrolase 2 |
44 |
0.93 |
chr1_65174300_65174494 | 1.05 |
Idh1 |
isocitrate dehydrogenase 1 (NADP+), soluble |
1167 |
0.4 |
chr16_17489473_17489624 | 1.05 |
Aifm3 |
apoptosis-inducing factor, mitochondrion-associated 3 |
63 |
0.95 |
chr19_7191764_7192280 | 1.05 |
Otub1 |
OTU domain, ubiquitin aldehyde binding 1 |
8442 |
0.13 |
chr6_90988613_90988968 | 1.05 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
105 |
0.97 |
chr4_12906721_12906911 | 1.05 |
Triqk |
triple QxxK/R motif containing |
22 |
0.99 |
chr12_84450990_84451534 | 1.05 |
Lin52 |
lin-52 homolog (C. elegans) |
160 |
0.62 |
chr5_92675213_92675578 | 1.04 |
Ccdc158 |
coiled-coil domain containing 158 |
124 |
0.96 |
chr5_115119038_115119366 | 1.04 |
Acads |
acyl-Coenzyme A dehydrogenase, short chain |
73 |
0.94 |
chr5_143112698_143112849 | 1.04 |
Rnf216 |
ring finger protein 216 |
207 |
0.9 |
chr1_128417328_128417495 | 1.03 |
Dars |
aspartyl-tRNA synthetase |
43 |
0.98 |
chr12_112675159_112675325 | 1.03 |
Akt1 |
thymoma viral proto-oncogene 1 |
358 |
0.75 |
chr2_174415705_174415861 | 1.02 |
Nelfcd |
negative elongation factor complex member C/D, Th1l |
21 |
0.96 |
chr8_107030950_107031349 | 1.02 |
Gm16208 |
predicted gene 16208 |
39 |
0.52 |
chr7_97788226_97788577 | 1.02 |
Pak1 |
p21 (RAC1) activated kinase 1 |
140 |
0.96 |
chr11_115319792_115319943 | 1.02 |
Ush1g |
USH1 protein network component sans |
2174 |
0.15 |
chr4_133241348_133241936 | 1.02 |
Map3k6 |
mitogen-activated protein kinase kinase kinase 6 |
824 |
0.47 |
chr7_45706938_45707229 | 1.02 |
Dbp |
D site albumin promoter binding protein |
21 |
0.92 |
chr11_43349655_43349816 | 1.02 |
Mir146 |
microRNA 146 |
24726 |
0.14 |
chr17_10319767_10319938 | 1.02 |
Qk |
quaking |
2 |
0.98 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.3 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
1.0 | 3.0 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.9 | 2.8 | GO:0001555 | oocyte growth(GO:0001555) |
0.9 | 3.8 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.8 | 2.5 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.8 | 5.7 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.6 | 1.9 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.6 | 1.9 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.6 | 3.0 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.5 | 1.6 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.5 | 4.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.5 | 1.6 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.5 | 1.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.5 | 1.9 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.4 | 1.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.4 | 2.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.4 | 1.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.4 | 0.4 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.4 | 1.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.4 | 1.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.3 | 1.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.3 | 1.3 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.3 | 1.0 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.3 | 1.3 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.3 | 0.9 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.3 | 1.3 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.3 | 1.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 2.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 0.9 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.3 | 2.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 0.8 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.3 | 0.8 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.3 | 0.8 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.3 | 0.8 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.3 | 1.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 0.5 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.3 | 1.3 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 1.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.3 | 0.8 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.3 | 0.5 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.3 | 0.8 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.3 | 0.8 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.3 | 0.8 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.3 | 2.1 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.3 | 0.8 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.3 | 0.8 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.3 | 1.3 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.3 | 1.8 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.3 | 0.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.2 | 0.5 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.2 | 0.2 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.2 | 0.7 | GO:0006227 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.2 | 0.5 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 0.7 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.2 | 0.7 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.2 | 0.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.2 | 1.0 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.2 | 1.2 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.2 | 1.6 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 0.7 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.2 | 0.9 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 0.5 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 1.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 1.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 3.4 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.2 | 0.9 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.2 | 0.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 0.7 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.2 | 0.2 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.2 | 1.5 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.2 | 0.7 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.2 | 0.7 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.2 | 1.1 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.2 | 0.6 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.2 | 0.6 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.2 | 1.5 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.2 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 1.1 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.2 | 1.1 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.2 | 0.4 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.2 | 0.8 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.2 | 1.0 | GO:0070627 | ferrous iron import(GO:0070627) |
0.2 | 0.6 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 0.8 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 1.0 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.2 | 0.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 0.2 | GO:1903273 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
0.2 | 0.6 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 0.8 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.2 | 1.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 0.4 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.2 | 0.4 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.2 | 0.6 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 1.0 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.2 | 0.6 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.2 | 0.8 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 0.6 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.2 | 0.8 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 0.4 | GO:0036394 | amylase secretion(GO:0036394) |
0.2 | 0.4 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.2 | 0.6 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.2 | 2.3 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.2 | 0.2 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.2 | 0.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.2 | 2.8 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.2 | 0.6 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.2 | 0.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 0.7 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 2.9 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.2 | 2.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.2 | 0.3 | GO:0046755 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.2 | 0.2 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.2 | 0.7 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 0.3 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.2 | 0.2 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.2 | 1.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.2 | 0.9 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.2 | 0.8 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.2 | 0.5 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.2 | 0.7 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 0.7 | GO:0048478 | replication fork protection(GO:0048478) |
0.2 | 0.5 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.2 | 0.9 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 0.8 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 0.6 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.2 | 0.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 0.5 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 0.5 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.2 | 0.5 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 0.5 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.2 | 0.3 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.2 | 0.6 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 0.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.6 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.2 | 0.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 0.6 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 0.5 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.3 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.9 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.1 | 0.9 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.4 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.1 | 0.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.6 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.4 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.1 | 1.1 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.1 | 1.6 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 0.3 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.4 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 | 0.7 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 1.4 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.7 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.1 | 0.6 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.7 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.8 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.7 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 0.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 4.5 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.4 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.1 | 0.5 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.1 | 0.5 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.3 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.1 | 0.3 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.5 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 0.7 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.8 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.3 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.1 | 0.3 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.1 | 0.4 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 0.8 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.7 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.3 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.9 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.5 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 0.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.9 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.1 | 0.5 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 1.6 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.1 | 0.5 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.4 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.1 | 0.3 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 0.5 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.1 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.5 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.1 | 0.9 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 1.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.5 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.7 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.1 | 0.6 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.4 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.1 | 0.4 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.1 | GO:0036257 | multivesicular body organization(GO:0036257) |
0.1 | 0.4 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.2 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.1 | 0.4 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.5 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 0.8 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 1.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.4 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 1.3 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.1 | 0.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.2 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.1 | 0.6 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.7 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.1 | 0.6 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.7 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.8 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.1 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) ureter morphogenesis(GO:0072197) |
0.1 | 3.6 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.8 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.7 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.4 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.4 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.1 | 0.4 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.1 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.1 | 0.3 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.1 | 1.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.8 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 1.6 | GO:0097576 | autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
0.1 | 0.1 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.1 | 1.0 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.1 | 1.3 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.1 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.4 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.5 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 1.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.3 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.1 | 0.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.4 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 0.2 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 0.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.3 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.1 | 0.7 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.1 | 1.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.4 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 0.4 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.2 | GO:0034239 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) |
0.1 | 0.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.4 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.1 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.3 | GO:0061010 | gall bladder development(GO:0061010) |
0.1 | 0.2 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.1 | 0.4 | GO:0090427 | activation of meiosis(GO:0090427) |
0.1 | 0.7 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 1.9 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 0.3 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.1 | 0.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.8 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.3 | GO:0046271 | phenylpropanoid metabolic process(GO:0009698) phenylpropanoid catabolic process(GO:0046271) |
0.1 | 0.7 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 0.4 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 1.0 | GO:0009435 | NAD biosynthetic process(GO:0009435) nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.1 | 0.2 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.2 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.3 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.1 | 0.3 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.1 | GO:0035789 | cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) regulation of metanephric mesenchymal cell migration(GO:2000589) |
0.1 | 0.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.5 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.1 | 0.2 | GO:0021564 | vagus nerve development(GO:0021564) |
0.1 | 2.6 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.2 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.1 | 0.8 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.3 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.3 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.3 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.1 | 0.6 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.7 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.4 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 0.2 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.1 | 0.3 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.1 | 0.4 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.5 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 0.3 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.3 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.1 | 0.5 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.1 | 0.2 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.1 | 0.2 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 0.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.1 | 0.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 1.2 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.7 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.1 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.6 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.3 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.7 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.3 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.4 | GO:0061727 | methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.5 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.5 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.7 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 3.0 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.1 | 0.4 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.1 | 0.8 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.2 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.1 | 0.4 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.1 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 0.1 | GO:0030540 | female genitalia development(GO:0030540) |
0.1 | 1.4 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.2 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.6 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.7 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.1 | 0.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.5 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.5 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 2.8 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.3 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.1 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.1 | 1.9 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.5 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.4 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.1 | 0.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.5 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.5 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.9 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.2 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.1 | 0.7 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.1 | 0.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.1 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 0.4 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.5 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 0.3 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.2 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.2 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 0.1 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.4 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.1 | 0.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.3 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.2 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.1 | 0.6 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 1.4 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 1.1 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 1.1 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.3 | GO:0070589 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.1 | 0.4 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.1 | 1.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.3 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.1 | 0.1 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.1 | 0.6 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.5 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 0.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.2 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 3.5 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.1 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.8 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.1 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.1 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.1 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.1 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.1 | 0.1 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.1 | 0.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.5 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.1 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
0.1 | 0.1 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.1 | 0.4 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.1 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
0.1 | 0.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.3 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 0.4 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 0.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.1 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.1 | 0.3 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.1 | 0.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.1 | GO:0033280 | response to vitamin D(GO:0033280) |
0.1 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.1 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.1 | 0.5 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.1 | 0.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 0.1 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.1 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.1 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.1 | 0.5 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 1.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.1 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.8 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.1 | GO:0038107 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.1 | 0.1 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
0.1 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.2 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 0.2 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.1 | 0.6 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.3 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.7 | GO:0021924 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.1 | 0.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.6 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
0.1 | 0.2 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.1 | 0.4 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.1 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.1 | 0.1 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.1 | 1.0 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.1 | 0.3 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.2 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.1 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.3 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.1 | 0.1 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.7 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.1 | 0.2 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 0.3 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.1 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.2 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.1 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.1 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.1 | 0.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.7 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 0.1 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.1 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 0.1 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.1 | 0.2 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.1 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.2 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.2 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
0.1 | 0.5 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 0.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.1 | 0.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 0.5 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 0.3 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.1 | 0.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.4 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.1 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.3 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.0 | 0.8 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.3 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 0.6 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.2 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 0.2 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.0 | 0.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.3 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.0 | 0.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.1 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.0 | 0.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.0 | 0.0 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.0 | 0.2 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 1.9 | GO:1901216 | positive regulation of neuron death(GO:1901216) |
0.0 | 0.3 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.0 | 0.6 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.0 | 0.0 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.0 | 0.4 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.0 | GO:0070344 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.0 | 0.2 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.0 | 0.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.0 | 0.9 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.6 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.0 | GO:0030035 | microspike assembly(GO:0030035) |
0.0 | 0.2 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.0 | 2.0 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
0.0 | 0.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.0 | 0.1 | GO:1902548 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.0 | 0.3 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.0 | 0.1 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.0 | 0.1 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.0 | 0.6 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.0 | 0.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.0 | 0.4 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 1.0 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.6 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.1 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.6 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
0.0 | 0.5 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.0 | 0.7 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.2 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.0 | 0.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.3 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.0 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.0 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.0 | 0.3 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.1 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.0 | 0.2 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.1 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.0 | 0.5 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.0 | 0.1 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.0 | 0.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.0 | 0.3 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.2 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.2 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.1 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.3 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 0.1 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.0 | 0.1 | GO:0009265 | 2'-deoxyribonucleotide biosynthetic process(GO:0009265) deoxyribose phosphate biosynthetic process(GO:0046385) |
0.0 | 0.5 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.0 | 0.2 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.0 | 0.1 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.0 | 0.4 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.1 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.0 | 0.3 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.2 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.0 | 0.7 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 1.1 | GO:0045471 | response to ethanol(GO:0045471) |
0.0 | 0.1 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.0 | 1.1 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.1 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.0 | 0.1 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.0 | 0.4 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.2 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.6 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.2 | GO:0071711 | basement membrane organization(GO:0071711) |
0.0 | 0.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.0 | 0.9 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.3 | GO:0043584 | nose development(GO:0043584) |
0.0 | 0.9 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 0.0 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
0.0 | 0.8 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.2 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.5 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.0 | 0.2 | GO:0072525 | pyridine-containing compound biosynthetic process(GO:0072525) |
0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.1 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.0 | 0.2 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.0 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.1 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.0 | 0.9 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.0 | 0.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.1 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.0 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.0 | 0.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.1 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.0 | 0.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.0 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.0 | 0.8 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 0.4 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.0 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.0 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.1 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.0 | 0.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.0 | 0.0 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.0 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.0 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.0 | 0.0 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.0 | 0.1 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.0 | 0.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.0 | 0.6 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.8 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.0 | 0.0 | GO:0032741 | dendritic cell cytokine production(GO:0002371) positive regulation of interleukin-18 production(GO:0032741) |
0.0 | 0.1 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.0 | 0.2 | GO:0015825 | L-serine transport(GO:0015825) |
0.0 | 0.3 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.0 | 0.2 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.0 | 0.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.0 | 0.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.6 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.0 | 0.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.0 | 0.2 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.0 | 0.1 | GO:0010872 | regulation of cholesterol esterification(GO:0010872) |
0.0 | 0.3 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.2 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.0 | 0.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.2 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.0 | 0.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.9 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.3 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.0 | 1.1 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.0 | 0.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.0 | 0.5 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.0 | 0.1 | GO:0060903 | regulation of meiosis I(GO:0060631) positive regulation of meiosis I(GO:0060903) |
0.0 | 0.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 0.3 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.0 | 0.0 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.0 | 0.0 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.0 | 0.1 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.0 | 0.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.9 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 0.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.1 | GO:0010755 | regulation of plasminogen activation(GO:0010755) positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.0 | 0.1 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 0.3 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.0 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.0 | 0.1 | GO:1902075 | cellular response to salt(GO:1902075) |
0.0 | 0.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.0 | 0.0 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.0 | 0.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.1 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.0 | 0.2 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 1.3 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 0.0 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.0 | 0.1 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.1 | GO:0042701 | progesterone secretion(GO:0042701) |
0.0 | 0.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.0 | 0.1 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.1 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.0 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.0 | 0.0 | GO:0003099 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.0 | 0.0 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.0 | 0.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.0 | 0.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.2 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.6 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.0 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.1 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.0 | GO:0072071 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
0.0 | 0.1 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.0 | 0.2 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.0 | 0.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.0 | 0.1 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.0 | 0.3 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.0 | 0.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.0 | GO:0072017 | distal tubule development(GO:0072017) |
0.0 | 0.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.1 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.0 | 0.1 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.0 | 0.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.0 | 0.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.0 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 1.4 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.3 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.0 | GO:0021586 | pons maturation(GO:0021586) |
0.0 | 0.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.4 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.0 | 0.0 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.7 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.0 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.0 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 0.1 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.3 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.2 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.0 | 0.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.0 | 0.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.0 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.1 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.0 | GO:0060426 | lung vasculature development(GO:0060426) |
0.0 | 0.1 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.0 | GO:0003284 | septum primum development(GO:0003284) |
0.0 | 0.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.1 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 0.1 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.3 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.0 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.0 | 0.0 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.1 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.0 | 0.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.0 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.0 | 0.0 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.0 | 0.1 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.0 | 0.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.4 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.0 | GO:0018214 | protein carboxylation(GO:0018214) |
0.0 | 0.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.0 | 0.0 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
0.0 | 0.0 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.0 | 0.0 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
0.0 | 0.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.2 | GO:0030325 | adrenal gland development(GO:0030325) |
0.0 | 0.4 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.5 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.0 | 0.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.0 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.0 | 0.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.0 | 0.2 | GO:0070166 | enamel mineralization(GO:0070166) |
0.0 | 0.1 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.0 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.0 | 0.1 | GO:0097286 | iron ion import(GO:0097286) |
0.0 | 0.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.0 | 0.1 | GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.0 | 0.0 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.0 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.0 | 0.1 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.1 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.1 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.1 | GO:0044088 | regulation of vacuole organization(GO:0044088) regulation of autophagosome assembly(GO:2000785) |
0.0 | 0.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.1 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
0.0 | 0.0 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.0 | 0.0 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.0 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.0 | 0.0 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 0.4 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.0 | 0.2 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.0 | GO:0034442 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
0.0 | 0.2 | GO:0035307 | positive regulation of protein dephosphorylation(GO:0035307) |
0.0 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.0 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
0.0 | 0.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.1 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.0 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 0.0 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.4 | GO:0045682 | regulation of epidermis development(GO:0045682) |
0.0 | 0.2 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.0 | 0.0 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.0 | 0.0 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.0 | 0.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.0 | 0.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.0 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.0 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.0 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.0 | 0.1 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.2 | GO:0031641 | regulation of myelination(GO:0031641) |
0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.0 | GO:0071611 | interleukin-3 production(GO:0032632) regulation of interleukin-3 production(GO:0032672) macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
0.0 | 0.1 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 0.5 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.0 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.0 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.0 | 0.1 | GO:1902745 | positive regulation of lamellipodium organization(GO:1902745) |
0.0 | 0.5 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.1 | GO:1990776 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.0 | 0.1 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.0 | 0.4 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.0 | GO:0051029 | rRNA transport(GO:0051029) |
0.0 | 0.0 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.0 | 0.1 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.0 | 0.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.0 | 0.1 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.3 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.0 | 0.0 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.0 | 0.1 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 0.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.0 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.1 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.0 | 0.2 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.0 | GO:0001796 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.0 | 0.4 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.5 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.2 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.1 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.1 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.3 | GO:0060996 | dendritic spine development(GO:0060996) |
0.0 | 0.0 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.1 | GO:0042119 | neutrophil activation(GO:0042119) |
0.0 | 0.2 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.0 | 0.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.0 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.0 | 0.0 | GO:0051610 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.0 | 0.0 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.0 | 0.1 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 0.1 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.2 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 0.2 | GO:0046427 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.0 | 0.0 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.0 | 0.1 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.0 | 0.2 | GO:0010458 | exit from mitosis(GO:0010458) |
0.0 | 1.9 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.0 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.0 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.0 | 0.0 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.0 | 0.0 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.0 | 1.6 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 0.0 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.0 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.0 | 0.0 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 0.1 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.0 | GO:0009147 | pyrimidine nucleoside triphosphate metabolic process(GO:0009147) |
0.0 | 0.1 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.0 | 0.1 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.0 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.0 | 0.1 | GO:0048854 | brain morphogenesis(GO:0048854) |
0.0 | 0.1 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 0.0 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.1 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.0 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.3 | GO:0007632 | visual behavior(GO:0007632) |
0.0 | 0.1 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.0 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.0 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
0.0 | 0.1 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 0.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.0 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.1 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.0 | 0.4 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.0 | 0.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.0 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.0 | 0.0 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.1 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.1 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.1 | GO:0009409 | response to cold(GO:0009409) |
0.0 | 0.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.0 | 0.1 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.8 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.0 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 0.0 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.0 | 0.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.0 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.0 | 0.1 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.1 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.0 | 0.1 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.0 | 0.0 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.2 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.0 | 0.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.0 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.1 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.0 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.0 | 0.1 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 0.0 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.0 | 1.1 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
0.0 | 0.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.2 | GO:1902117 | positive regulation of organelle assembly(GO:1902117) |
0.0 | 0.0 | GO:0034755 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) iron ion transmembrane transport(GO:0034755) |
0.0 | 0.0 | GO:0007619 | courtship behavior(GO:0007619) |
0.0 | 0.0 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.0 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.0 | 0.1 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 0.1 | GO:0060740 | prostate gland epithelium morphogenesis(GO:0060740) |
0.0 | 0.0 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.0 | 0.0 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.0 | 0.0 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.0 | 0.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.0 | 0.1 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.0 | 0.0 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 0.0 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.0 | 0.0 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.0 | GO:0030878 | thyroid gland development(GO:0030878) |
0.0 | 0.0 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.0 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.0 | 0.0 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.0 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.0 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.0 | 0.1 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.0 | 0.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.0 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.0 | GO:0051608 | histamine transport(GO:0051608) |
0.0 | 0.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0071025 | RNA surveillance(GO:0071025) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.0 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.0 | 0.0 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.0 | 0.0 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.0 | 0.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.3 | GO:0045778 | positive regulation of ossification(GO:0045778) |
0.0 | 0.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.3 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.0 | 0.1 | GO:0030818 | negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) negative regulation of cAMP biosynthetic process(GO:0030818) |
0.0 | 0.0 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.0 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.0 | 0.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.0 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.0 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.0 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.0 | 0.0 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.0 | 0.0 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.0 | 0.3 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.0 | 0.0 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.0 | 0.0 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.0 | 0.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.0 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 0.0 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.0 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.0 | 0.0 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.0 | 0.1 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.0 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.1 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.3 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.0 | 0.6 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.0 | GO:0018095 | protein polyglutamylation(GO:0018095) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 3.0 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.6 | 5.4 | GO:0036128 | CatSper complex(GO:0036128) |
0.5 | 1.6 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.5 | 1.8 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.4 | 4.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 1.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 1.0 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.3 | 1.0 | GO:0035061 | interchromatin granule(GO:0035061) |
0.3 | 2.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 6.3 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 1.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 1.2 | GO:0032021 | NELF complex(GO:0032021) |
0.3 | 0.8 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.3 | 0.8 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 1.1 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.3 | 1.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.3 | 0.3 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.3 | 1.6 | GO:0001739 | sex chromatin(GO:0001739) |
0.3 | 0.8 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 0.9 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 2.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 0.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.2 | 2.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 1.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 1.2 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 0.8 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 0.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 1.4 | GO:0000801 | central element(GO:0000801) |
0.2 | 0.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 0.7 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 1.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 0.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 0.7 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.2 | 1.4 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.7 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 0.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 1.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 0.5 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.2 | 2.0 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 1.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 1.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 0.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 0.5 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.7 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.9 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.7 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.8 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 2.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.8 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.4 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 0.5 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 0.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.2 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.1 | 0.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.9 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 2.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 1.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.3 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 1.9 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 0.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 1.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.3 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 2.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 1.1 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.8 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.9 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 1.6 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.5 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 0.4 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.9 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.4 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 0.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 2.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 4.2 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 0.9 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 1.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.9 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.3 | GO:0000235 | astral microtubule(GO:0000235) |
0.1 | 1.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 1.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 1.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 1.4 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.9 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.3 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 0.2 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 4.3 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 0.3 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.4 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.1 | 0.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.6 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 0.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.3 | GO:0000803 | sex chromosome(GO:0000803) |
0.1 | 0.6 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.4 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.3 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 1.9 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.3 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 1.7 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.3 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 0.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.4 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.5 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.9 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.4 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.1 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.4 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 1.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.2 | GO:0097441 | basilar dendrite(GO:0097441) |
0.1 | 1.0 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.7 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.3 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.2 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 2.6 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.3 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 0.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.1 | 1.6 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 3.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.9 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 1.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 3.5 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.8 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.3 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.2 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 0.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 0.3 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.4 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 1.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 2.3 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.3 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.7 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.0 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.0 | 0.0 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.0 | 0.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 1.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 2.7 | GO:0034399 | nuclear periphery(GO:0034399) |
0.0 | 0.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 1.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.3 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.0 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.5 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.1 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.6 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.4 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.2 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 1.0 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.2 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.5 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.2 | GO:0097449 | astrocyte projection(GO:0097449) |
0.0 | 0.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.3 | GO:0030496 | midbody(GO:0030496) |
0.0 | 4.0 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 1.8 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.7 | GO:0036379 | myofilament(GO:0036379) |
0.0 | 0.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 10.9 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 1.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 1.0 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.0 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.0 | 0.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 1.5 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 0.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 1.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 17.4 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.9 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 2.5 | GO:0044450 | microtubule organizing center part(GO:0044450) |
0.0 | 0.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.0 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 0.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.4 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 0.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.2 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.3 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.0 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 0.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.1 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.1 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.0 | 1.1 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.5 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 10.4 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.4 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.3 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.0 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.5 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.4 | GO:0000786 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.0 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 3.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.1 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 0.1 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.4 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.0 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.4 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.4 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.4 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.0 | 0.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 1.1 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.4 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.8 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.2 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 2.5 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.0 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.0 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.1 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.5 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.0 | 0.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.0 | 2.2 | GO:0005635 | nuclear envelope(GO:0005635) |
0.0 | 0.1 | GO:0097346 | INO80-type complex(GO:0097346) |
0.0 | 1.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.8 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.1 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.1 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.3 | GO:0098793 | presynapse(GO:0098793) |
0.0 | 0.0 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.0 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.0 | 0.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 0.0 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.0 | 0.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.0 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 1.8 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 5.8 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.4 | GO:0005604 | basement membrane(GO:0005604) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.7 | 2.2 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.6 | 1.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.5 | 1.6 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.5 | 2.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.4 | 2.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.4 | 2.0 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.4 | 1.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.4 | 1.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.4 | 1.6 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.3 | 0.3 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.3 | 1.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.3 | 1.7 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 1.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.3 | 1.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.3 | 1.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.3 | 2.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 0.8 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.3 | 0.8 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 4.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 1.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 0.7 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 0.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 1.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.2 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.2 | 1.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 0.6 | GO:0004802 | transketolase activity(GO:0004802) |
0.2 | 1.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.6 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.2 | 0.8 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 5.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 1.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 0.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 1.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 0.6 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 2.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 1.1 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 1.6 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 0.9 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.2 | 1.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.2 | 0.7 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.2 | 1.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 0.5 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 3.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 0.5 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 0.9 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 0.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 2.0 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 2.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 0.8 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 1.2 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.2 | 0.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 1.0 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 1.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.6 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 1.6 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 0.8 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.2 | 0.5 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 2.3 | GO:0043748 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.2 | 0.5 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 0.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 0.9 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 10.8 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 1.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.4 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.7 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 1.7 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.4 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 0.7 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 0.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.4 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 1.0 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 2.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.3 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 1.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.8 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.3 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 0.6 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.8 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 0.7 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.7 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.5 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 1.4 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.9 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 1.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.7 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 0.3 | GO:0008412 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.1 | 0.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 1.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.7 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 3.8 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.5 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 1.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.4 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.5 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.1 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.1 | 0.5 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.1 | 0.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.7 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 1.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.5 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.3 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 0.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.8 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.1 | 0.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.3 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.3 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.1 | 0.6 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.2 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 0.8 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.6 | GO:0018643 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.1 | 0.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 1.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 0.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 1.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.7 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.8 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 1.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.5 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.7 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 0.5 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.5 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 2.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 1.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.5 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.2 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.5 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.2 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.1 | 1.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 1.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 1.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 1.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.2 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 1.0 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 0.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.8 | GO:0052890 | acyl-CoA dehydrogenase activity(GO:0003995) oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.1 | 0.5 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 0.3 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 1.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 1.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 0.7 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 1.9 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 0.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 0.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 7.4 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 2.0 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.1 | 0.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.6 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 0.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 2.2 | GO:0018733 | 3,4-dihydrocoumarin hydrolase activity(GO:0018733) |
0.1 | 0.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.5 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.3 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.2 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 1.0 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 1.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.4 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 1.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 0.9 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 1.1 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.5 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.2 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.3 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 2.5 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 1.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.4 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 1.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 1.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 2.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 4.3 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 0.8 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 3.5 | GO:0019955 | cytokine binding(GO:0019955) |
0.1 | 1.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.1 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.6 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.7 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.4 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.1 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 1.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 1.9 | GO:0019209 | kinase activator activity(GO:0019209) |
0.0 | 0.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.0 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.0 | 0.4 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.0 | 0.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.0 | 0.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.1 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.0 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.5 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.3 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.0 | 3.2 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.0 | 5.8 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.0 | 0.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.8 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.0 | 0.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.2 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.0 | 1.0 | GO:0043738 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) NADPH:sulfur oxidoreductase activity(GO:0043914) epoxyqueuosine reductase activity(GO:0052693) |
0.0 | 0.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.1 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.1 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.0 | 0.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.6 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.0 | 0.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 1.2 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.4 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.4 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.1 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.0 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) glycine:sodium symporter activity(GO:0015375) |
0.0 | 0.4 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.3 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 1.2 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.0 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.9 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.0 | 1.5 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 1.0 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 2.7 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 1.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.1 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.0 | 0.1 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.0 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 1.4 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 1.3 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.0 | 0.1 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.3 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 2.1 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.0 | 0.7 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.0 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.0 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.1 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.6 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.3 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 4.5 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.7 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 0.1 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.5 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.5 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.0 | 0.3 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.0 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.0 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.2 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 2.2 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.1 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 0.3 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.2 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.6 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.0 | 0.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.4 | GO:0000907 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) DNA-N1-methyladenine dioxygenase activity(GO:0043734) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.0 | 0.0 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.8 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 2.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.0 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 1.6 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.0 | 0.0 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.1 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.2 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 1.4 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.0 | 0.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.0 | GO:0034046 | poly(G) binding(GO:0034046) |
0.0 | 0.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.0 | GO:0051379 | epinephrine binding(GO:0051379) |
0.0 | 0.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.1 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.0 | 0.3 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.2 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.3 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.5 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 4.5 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 1.7 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.0 | 0.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.1 | GO:0008828 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.0 | 0.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.0 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.1 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.1 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.0 | 0.1 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.1 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.0 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.0 | 0.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.0 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.7 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.1 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 0.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 1.0 | GO:0020037 | heme binding(GO:0020037) tetrapyrrole binding(GO:0046906) |
0.0 | 0.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 1.6 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 1.6 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 2.9 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.0 | 0.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 1.4 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.0 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.1 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.1 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.3 | GO:0015631 | tubulin binding(GO:0015631) |
0.0 | 0.0 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.2 | GO:0005126 | cytokine receptor binding(GO:0005126) |
0.0 | 0.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.0 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.0 | 0.1 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.0 | GO:0050542 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.0 | 0.3 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.6 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.0 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 6.3 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.0 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.0 | 0.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 1.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.0 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.0 | 0.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.5 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.0 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.0 | 0.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.3 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.0 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.0 | GO:0030580 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 4.9 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 7.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 2.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 4.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 0.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 2.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 1.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 1.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 3.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 2.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 4.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 3.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 4.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 2.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 0.9 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 0.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 3.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 2.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 2.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 1.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 1.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 1.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 2.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 2.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 1.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.8 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 1.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 1.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 1.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 1.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 1.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 1.0 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 1.9 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 1.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 2.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 1.4 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 1.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.7 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 1.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 4.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 2.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 4.1 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.2 | 5.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 2.4 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 1.5 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.2 | 1.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 2.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 1.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 2.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 1.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 2.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 2.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 2.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 2.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 3.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 5.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 2.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 2.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 1.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 1.1 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 1.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 3.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 1.6 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.1 | 0.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 1.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 1.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.8 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 0.6 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 2.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 2.3 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 0.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 0.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 0.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 0.8 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.5 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.1 | 1.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.9 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.1 | 0.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 1.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 1.8 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.1 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 0.5 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 1.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.4 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 0.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.6 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 0.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.7 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.5 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.0 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 2.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.7 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 1.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 1.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.6 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 1.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.8 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.0 | 1.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.5 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.6 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.3 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 1.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.2 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.0 | 0.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.3 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.0 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 1.1 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.0 | 0.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.5 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.0 | 0.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.2 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.0 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.0 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 1.1 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.0 | 0.0 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 0.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.2 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.0 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 0.1 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |